Ocular immune privilege: therapeutic opportunities from an experiment of nature
Top Cited Papers
- 1 November 2003
- journal article
- review article
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 3 (11) , 879-889
- https://doi.org/10.1038/nri1224
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- Iris Pigment Epithelium Expressing CD86 (B7-2) Directly Suppresses T Cell Activation In Vitro via Binding to Cytotoxic T Lymphocyte–associated Antigen 4The Journal of Experimental Medicine, 2003
- Corneal LymphangiogenesisCornea, 2003
- The eye’s view of antigen presentationHuman Immunology, 2002
- CD1d on antigen-transporting APC and splenic marginal zone B cells promotes NKT cell-dependent toleranceEuropean Journal of Immunology, 2002
- Thrombospondin-1, a Natural Inhibitor of Angiogenesis, Is Present in Vitreous and Aqueous Humor and Is Modulated by HyperglycemiaBiochemical and Biophysical Research Communications, 2000
- SHORT COMMUNICATION: Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyesCurrent Eye Research, 1997
- Novel production of interleukin-1 receptor antagonist peptides in normal human cornea.Journal of Clinical Investigation, 1995
- Indirect presentation of MHC antigens in transplantationImmunology Today, 1994
- ORTHOTOPIC CORNEAL TRANSPLANTATION IN MICE—EVIDENCE THAT THE IMMUNOGENETIC RULES OF REJECTION DO NOT APPLYTransplantation, 1992
- Studies on the problem of corneal homograftsProceedings of the Royal Society of London. B. Biological Sciences, 1953